PMID: 42117741

Sexual function outcomes of the 5-year treatment with Rezum compared to doxazosin, finasteride, and combination drug therapy for men with benign prostatic hyperplasia: cohort data from the Medical Therapy of Prostatic Symptoms Trial.

Han Timothy M, Helon Jessica, Long Bronwyn, Cheema Amandip, Gonzalez Nicholas, Joyce Cara, Feffer Marina, McVary Kevin T

The journal of sexual medicine · 2026

Vol. 23, Issue 6

View on PubMedDOI

This entry links to third-party literature. For research use only.

HumansMaleProstatic HyperplasiaDoxazosinFinasteride5-alpha Reductase InhibitorsAgedDrug Therapy, CombinationMiddle AgedLower Urinary Tract Symptoms

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.